Core Insights - Shanghai Ruici Medical Investment Group and Shanghai Institute of Major Infectious Diseases and Biosecurity signed a strategic cooperation agreement to advance chronic disease health examination standards and collaborate in preventive medicine [1] Group 1: Strategic Cooperation - The agreement aims to establish scientific health examination standards and address potential health management needs [1] - Both parties will leverage their strengths in medical services and technological innovation to enhance public health services and cultivate medical research talent [1] Group 2: Organizational Background - The Shanghai Institute of Major Infectious Diseases and Biosecurity was approved by the Shanghai Municipal Government in July 2020 and officially established in November 2020 [2] - It operates as a public welfare research institution jointly built by the Shanghai Municipal Government and Fudan University, managed under a council-led system [2]